InChI=1S/C23H33NO5S/c1- 15- 6- 5- 7- 21- 22(15,3) 9- 8- 16(2) 23(21,4) 14- 17- 12- 20(26) 18(13- 19(17) 25) 24- 10- 11- 30(27,28) 29/h6,12- 13,16,21,24H,5,7- 11,14H2,1- 4H3,(H,27,28,29) /t16- ,21+,22+,23+/m0/s1 |
DTNJUMSQZGAJQJ-RAKGIWIYSA-N |
[H][C@@]12CCC=C(C)[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=CC(=O)C(NCCS(O)(=O)=O)=CC1=O |
|
Dysidea avara
(NCBI:txid196820)
|
See:
DOI
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
tyrosine kinase inhibitor
Any protein kinase inhibitor that interferes with the action of tyrosine kinase.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
View more via ChEBI Ontology
2- [(3,6- dioxo- 4- {[(1R,2S,4aS,8aS)- 1,2,4a,5- tetramethyl- 1,2,3,4,4a,7,8,8a- octahydronaphthalen- 1- yl]methyl}cyclohexa- 1,4- dien- 1- yl)amino]ethanesulfonic acid
|
5887590
|
Reaxys Registry Number
|
Reaxys
|
|